首页 > 市场调查报告书 > 医疗设备

医学影像诊断内视镜检查设备

市场调查报告书

商品编码

1319133

全球内窥镜后处理市场 - 2023-2030 年

Global Endoscope Reprocessing Market - 2023-2030

出版日期: 2023年07月31日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

2022 年，全球内窥镜后处理市场规模达到 23 亿美元，预计到 2030 年将达到 45 亿美元，2023-2030 年的年均复合增长率为 9.2%。）医疗保健意识的增强、技术的进步（如集成连接功能、数据跟踪和远程监控功能）推动了内窥镜再处理市场需求的增长趋势。

内窥镜再处理对于预防感染方法和确保医疗操作过程中的患者安全至关重要。内窥镜再处理对于确保有效清除污染和降低医疗相关疾病的风险至关重要。超声波清洗器、消毒器、清洗消毒器、干燥和储存柜、内窥镜跟踪系统以及其他解决方案都包括在市场中。

全球内窥镜后处理市场的范围包括产品类型、高级消毒剂和试纸、清洁剂和湿巾、自动内窥镜后处理器、内窥镜干燥、存储和运输系统等，这些产品的使用增加了内窥镜后处理的市场份额。

全球内窥镜后处理市场不断扩大的因素包括：医疗相关感染（HAI）发病率上升、内窥镜手术数量增加、患者安全日益受到重视、微创手术日益受到青睐以及老年人口不断增加。

市场动态

老年人口的增加预计将推动内窥镜后处理市场的增长

预计不断增长的老年人口将推动内窥镜后处理行业向前发展。随着老年人口的增长，对内窥镜手术等医疗服务的需求也在增长。老年病人经常需要更定期的医疗检查和诊断程序，包括使用内窥镜。内窥镜再处理对于确保这些程序的安全性和有效性至关重要。

例如，根据世界卫生组织（WHO）2022 年的报告，到 2030 年，地球上每六个人中就有一个是 60 岁或以上的老人。在这一时间跨度内，世界 60 岁及以上人口的比例预计将从 2020 年的 10 亿增加到 14 亿。因此，不断增长的老年人口增加了对内窥镜再处理的需求，推动了市场的发展。

对微创手术日益增长的偏好是全球内窥镜后处理市场的主要驱动力

与传统手术技术相比，微创手术具有显著优势，因此越来越受欢迎。这些优势包括减少不适感、缩短住院时间、减少问题、减少疤痕和组织损伤。影响患者、医疗服务提供商和整个行业的各种因素推动了微创手术的日益普及。内窥镜再处理是实现微创手术的关键。内窥镜消毒可通过人工或机器完成。

腹腔镜微创手术的增加是推动市场发展的主要因素。例如，根据克利夫兰诊所组织 2022 年的文章，全球每年进行 1300 万例腹腔镜手术。预计在未来五年内，这些数字还将增长 1%。随着微创手术需求的增长，对有效、可靠的内窥镜再处理解决方案的要求也随之提高。

缺乏合格的专业人员将阻碍市场增长

缺乏合格的专业人员来有效监控内窥镜后处理设备是一个关键的商业限制因素。对这些系统进行适当的监控和维护是确保内窥镜成功消毒和灭菌的关键。然而，设备的复杂性和操作所需的专业知识对合格的专业人员产生了需求。

这类技术人员的短缺会给系统性能、遵守安全规定和保证病人安全带来问题。解决这一短缺问题以及为技术人员提供适当的培训和资源，是克服这一制约因素和支持扩大内窥镜再处理业务的关键组成部分。

COVID-19 影响分析

COVID-19 大流行对内窥镜后处理市场产生了重大影响，人们更加重视感染预防和控制方法。个人防护设备需求的增加以及供应链问题影响了后处理设备和用品的供应和成本。内窥镜手术和病人数量的变化，特别是非急诊手术的推迟，影响了对再处理服务的需求。

远程医疗和远程监控的使用增加了对新型再处理解决方案的需求。医疗机构已将卫生和再处理实践列为优先事项，如改进清洁、员工培训和监控。

例如，美国国家医学图书馆 2021 年发表的一篇文章指出，为确保内窥镜的安全再处理，建议采取某些预防措施，包括手套、防护服、面罩和其他设备。这主要强调了在不久的将来行业发展对这些措施的需求。总之，COVID-19 大流行需要不断提高警惕并进行修改，以确保整个内窥镜手术过程中的患者安全。

俄乌战争影响分析

俄罗斯和乌克兰之间的持续冲突对内窥镜再处理行业产生了相当大的影响。入侵和由此引发的事件给供应链造成了障碍，导致元件短缺、物流挑战和成本增加。

这些困难再加上通胀压力，影响了医疗客户的财务状况。此外，大流行病的持续影响也减缓了医疗服务的恢复速度，尤其是择期手术。在这种环境下，提高医疗生产力变得越来越重要，而内窥镜再处理领域的智能产品和服务有助于满足这一需求。

Market Overview

The Global Endoscope Reprocessing Market reached US$ 2.3 billion in 2022 and is expected to reach US$ 4.5 billion by 2030 growing with a CAGR of 9.2% during the forecast period 2023-2030). The growing awareness of healthcare, advancement in technologies such as integration of connectivity features, data tracking, and remote monitoring capabilities are driving up demand for endoscope reprocessing market trends.

Endoscope reprocessing is critical in infection prevention methods and for ensuring patient safety during medical operations. Endoscope reprocessing is critical for guaranteeing effective contamination removal and lowering the risk of healthcare-associated illnesses. Ultrasonic washers, sterilizers, washer disinfectors, drying and storage cabinets, endoscope tracking systems, and other solutions are included in the market.

The global endoscope reprocessing market scope comprises components encompassing product types, high-level disinfectants and test strip, detergents and wipes, automated endoscope reprocessors, endoscope drying, storage, and transport systems which has increased usage of endoscope reprocessing market share.

The global market for endoscope reprocessing is expanding as a result of factors including rising prevalence of healthcare-associated infections (HAI's), increasing number of endoscopic procedures, increasing focus on patient safety, increasing preference for minimally invasive surgeries, and growing geriatric population.

Market Dynamics

Rising Geriatric Population is Estimated to Drive the Growth of the Endoscope Reprocessing Market

The growing geriatric population is projected to propel the endoscope reprocessing industry forwards. As the older population grows, so does the demand for healthcare services such as endoscopic procedures. Geriatric patients frequently require more regular medical examinations and diagnostic procedures including the use of endoscopes. Endoscope reprocessing is critical to ensuring the safety and effectiveness of these procedures.

For instance, according to World Health Organization (WHO) 2022 report, by 2030, about one out of every six people on the planet will be 60 or older. Within this time span, the share of the world population aged 60 and up is expected to increase from 1 billion in 2020 to 1.4 billion. As a result, the growing elderly population adds to an increased demand for endoscope reprocessing, propelling the market forwards.

Rising Preference toward Minimal Invasive Procedures is the Major Driver in the Global Endoscope Reprocessing Market

Minimally invasive operations are becoming increasingly popular due to their significant advantages over traditional surgical techniques. These advantages include less discomfort, shorter hospital stays, fewer problems, less scarring, and less tissue damage. The growing popularity of minimally invasive surgeries is being driven by a variety of factors affecting patients, healthcare providers, and the industry as a whole. Endoscopic reprocessing is critical in enabling minimally invasive operations. Endoscope disinfection can be done manually or using machines.

The rising laproscopic minimal invasive surgeries is major factor to drive the market. For instance, according to Cleveland Clinic organization 2022 article, every year, 13 million laparoscopic surgeries are performed worldwide. These figures are expected to rise by 1% during the following five years. As the need for minimally invasive surgeries grows, consequently rises the requirement for effective and dependable endoscopic reprocessing solutions.

Lack of Qualified Professional will Hamper the Growth of the Market

The lack of qualified professionals to effectively monitor endoscopic reprocessing equipment is a key commercial limitation. The appropriate monitoring and maintenance of these systems are critical to ensuring successful disinfection and sterilization of endoscopes. However, the complexity of the equipment and the specialized expertise necessary for its operation creates a demand for qualified specialists.

The shortage of such technicians causes issues in terms of system performance, compliance with safety regulations, and guaranteeing patient safety. Addressing this shortfall, as well as providing proper training and resources for technicians, are critical components in overcoming this constraint and supporting the expansion of the endoscopic reprocessing business.

COVID-19 Impact Analysis

The COVID-19 pandemic had a major effect on the endoscope reprocessing market, with a greater emphasis on infection prevention and control methods. Increased demand for personal protection equipment, as well as supply chain problems, have impacted the availability and cost of reprocessing equipment and supplies. Endoscopy procedures and patient volume change, especially the deferral of non-urgent operations, have influenced the demand for reprocessing services.

The use of telemedicine and remote monitoring has increased the demand for novel reprocessing solutions. Healthcare facilities have prioritized hygiene and reprocessing practices, such as improved cleaning, employee training, and monitoring.

For instance, according to National Library of Medicine article published in 2021, stated that to ensure the safe reprocessing of endoscopes, certain precautions, which include gloves, gowns, face shields, and other equipment, are advised. That mainly, emphasizes the need for such measures for the industry's growth in the near future. Overall, the COVID-19 pandemic has required constant vigilance and modification to guarantee patient safety throughout endoscopic procedures.

Russia-Ukraine War Impact Analysis

The ongoing conflict between Russia and Ukraine has had a considerable impact on the endoscope reprocessing sector. The invasion and resulting events have produced hurdles in the supply chain, resulting in component shortages, logistical challenges, and increased costs.

These difficulties, combined with inflationary pressures, have impacted the financial status of healthcare clients. Furthermore, the pandemic's continued impacts have slowed the recovery of healthcare services, notably elective surgeries. Improving healthcare productivity has become increasingly crucial in this environment, and smart products and services in the field of endoscope reprocessing can help to meet this demand.

Segment Analysis

The global endoscope reprocessing market is segmented based on product, end user and region.

Hospitals Segment Accounts for 41.1% of Market Share Owing to the Usage of Endoscopic Devices

Hospitals are important consumers of endoscopes, using them in a variety of diagnostic and therapeutic procedures such as gastrointestinal, urological, and pulmonary interventions. Because of the high volume of surgical procedures performed in hospitals, there is an elevated danger of cross-contamination and the spread of infections. To overcome this issue, hospitals are widely implementing sterilizers, automated endoscope reprocessors, and other advances in technology.

For instance, in April 2023, Children's Hospital Los Angeles (CHLA) became the first healthcare centre in California to use the EvoEndo Single-Use Endoscopy System for diagnostic unsedated TNE procedures of the Upper Gastrointestinal (GI) Tract. So to assure the safety and effectiveness of endoscopic treatments, they prioritize the use of efficient and dependable reprocessing methods. Endoscope cleaning, disinfection, and sterilization are handled by dedicated reprocessing departments or facilities equipped with specialized equipment and well-trained people.

Furthermore, hospitals exhibit a commitment to preventing cross-contamination and infections by striving to maintain strict reprocessing procedures and standards. The hospital segment's dominance in the endoscope reprocessing market can be ascribed to the large volume of endoscopic procedures conducted in hospitals, as well as their continuous commitment to patient safety and infection control. Thus, owing to the above factors the segment is expected to grow over the forecast period.

Geographical Analysis

North America Accounted for Approximately 39.3% of the Market Share Owing to the Increasing Collaborations

North America is likely to maintain its dominant position in the market due to increased investments and collaborations. The region's hostile commitment to encouraging breakthroughs and developments in endoscope reprocessing technology has garnered considerable investments from industrial players and academic organizations. Collaborations between healthcare providers, manufacturers, and regulatory authorities have also contributed to the market's rise.

For instance, in January 2023, AA Medical, a company dedicated to providing sustainable solutions for the new and resale medical device equipment sectors, announced a successful collaboration with Certified Endoscopy Products, a well-known medical device reprocessing company situated in Chicago. This collaboration seeks to gain a dominant market position by delivering high-quality reprocessing services for endoscopic equipment, as well as catering to the orthopedic and other surgical device sectors. Thus owing to the above factors the region is expected to dominate the market over the forecast period.

Competitive Landscape

The major global players in the endoscope reprocessing market include: Cantel Medical, Ecolab Inc, STERIS plc., Olympus Corporation, Getinge AB, Belimed AG , CONMED Corporation, Laboratoires Anios, SciCan Inc., HOYA Corporation, among others.

Why Purchase the Report?

To visualize the global endoscope reprocessing market segmentation based on product, end user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of endoscope reprocessing market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global endoscope reprocessing market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by End User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Geriatric Population
  - 4.1.1.2. Rising Preference toward Minimal Invasive Procedures
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Qualified Professional
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. High-Level Disinfectants and Test Strips*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Detergents and Wipes
7.4. Automated Endoscope Reprocessors
7.5. Endoscope Drying, Storage, and Transport Systems
7.6. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgery Centers
8.4. Other

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. U.K.
  - 9.3.5.3. France
  - 9.3.5.4. Spain
  - 9.3.5.5. Italy
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Cantel Medical*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Ecolab Inc
11.3. STERIS plc.
11.4. Olympus Corporation
11.5. Getinge AB
11.6. Belimed AG
11.7. CONMED Corporation
11.8. Laboratoires Anios
11.9. SciCan Inc.
11.10. HOYA Corporation

LIST NOT EXHAUSTIVE